NCT06784726
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Explore clinical trials studying Refractory Diffuse Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
NCT06784726
NCT06859008
NCT03418038
NCT07042438
NCT05800405
NCT05633615
NCT05890352
NCT06047197
NCT04920617